Trading a TRAX straddle lets you take a pure volatility position on First Tracks Biotherapeutics Inc without committing to a direction. First Tracks Biotherapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate TRAX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on TRAX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when First Tracks Biotherapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the TRAX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the TRAX straddle is the cleanest expression of that view. Our scanner prices every TRAX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a TRAX straddle into a catalyst or short a TRAX straddle to harvest decay, the options straddle setups that matter are all in one place.
